Sept 30 (Reuters) - AB Science SA ABS.PA :
* NET LOSS OF 8,8M€ IN THE FIRST HALF OF 2020, A DECREASE OF
32,4%
AS COMPARED WITH THE FIRST HALF OF 2019
* CASH POSITION OF 10.6M€ AS OF 30 JUNE 2020, PLUS 4.1M€ OF
2019
TAX CREDIT TO BE REIMBURSED BY THE PUBLIC FINANCE DEPARTMENT
* CASH BURN AMOUNTS TO 8,1M€ FOR THE FIRST HALF OF 2020, AS
COMPARED WITH 11.2M€ FOR THE FIRST HALF OF 2019 (-27%)
* OPERATING EXPENSES AMOUNTED TO 7,702 K€ ON 30 JUNE 2020 AS
COMPARED WITH 11,370 K€ ON 30 JUNE 2019, CORRESPONDING TO A
DECREASE OF 32.3%
* THE OPERATING LOSS AS AT 30 JUNE 2020 AMOUNTED TO 6,895 K€
AS
COMPARED WITH 10,579 K€ AS OF 30 JUNE 2019, WHICH IS A DECREASE
OF THE OPERATING LOSS BY 3,684 K€ (34.8%).
* THE FINANCIAL LOSS AS OF 30 JUNE 2020 WAS 1,897 K€, AS
COMPARED
WITH A LOSS OF 2,434 K€ A YEAR EARLIER.
* IN 2020, AB SCIENCE CONTINUES TO ALLOCATE MOST OF ITS
RESOURCES
TO THE DEVELOPMENT OF MASITINIB, THE MOST ADVANCED MOLECULE OF
THE COMPANY
Source text for Eikon: ID:nGNX64VnC2
Further company coverage: ABS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))